NEUP
Neuphoria Therapeutics
NEUP
NEUP
9 hedge funds and large institutions have $2.06M invested in Neuphoria Therapeutics in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
68% less capital invested
Capital invested by funds: $6.52M → $2.06M (-$4.46M)
Holders
9
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$281K | |
| 2 | +$46.3K | |
| 3 | +$17.8K | |
| 4 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
+$13K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.29K |
Top Sellers
| 1 | -$1.89M | |
| 2 | -$489K | |
| 3 | -$454K | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
-$128K |
| 5 |
VF
Virtu Financial
New York
|
-$45K |